Corporate News

Posting of Annual Report and confirmation of AGM

27 September 2022

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, confirms that the Notice of Annual General Meeting ('AGM') along with the Annual Report and Accounts for the year ended 31 March 2022 has been posted to shareholders yesterday afternoon and will shortly be made available on the Company's website at:

https://www.omegadiagnostics.com/Investor-Relations/Corporate-Information/Annual-Report-and-Interim-Results  

As previously announced, the AGM of the Company will be held on Wednesday 26 October 2022 at 11.00am at Poets House, St Mary's Street, Ely, CB7 4EY.

Contacts:  

Omega Diagnostics Group PLC  www.omegadx.com
Jag Grewal Chief Executive Officervia Walbrook PR
Chris Lea, Chief Financial Officer  
  
finnCap LtdTel: 020 7220 0500
Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)  
Alice Lane/ Charlotte Sutcliffe (ECM)  
  
Walbrook PR Limited Tel: 020 7933 8780 or [email protected]
Paul McManus Mob: 07980 541 893
Lianne Applegarth Mob: 07584 391 303
Sam Allen Mob: 07502 558 258

About Omega Diagnostics Group PLC  

Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and specialise in the areas of health and nutrition and global health. www.omegadx.com

Sign up for Investor Alerts